BIO logo

  • June 3-6, 2024
  • San Diego Convention Center, California

Presenting Companies

Join these innovators to learn about their breakthroughs in new products under development.

Loading
Search Filters
  • Date
  • Focus Area
We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Loading
  1. AaviGen
    CP
    • Cell and Gene Therapy and Genome Editing
    Patrick Most
    Patrick Most, CEO - AaviGen
  2. AAVogen
    CP
    • Cell and Gene Therapy and Genome Editing
    Buel Rodgers
    Buel Rodgers, CEO - AAVogen
  3. Accelerated Biosciences Corp.
    CP
    • Cell and Gene Therapy and Genome Editing
    Yuta Lee
    Yuta Lee, CEO - Accelerated Biosciences Corp.
  4. Accession Therapeutics Limited
    CP
    • Oncology
  5. Accuredit Therapeutics US limited
    CP
    • Cell and Gene Therapy and Genome Editing
    Yongzhong Wang
    Yongzhong Wang, CEO - Accuredit Therapeutics US Limited
  6. Accuronix Therapeutics, Inc.
    CP
    • Oncology
    Bradley Keller
    Bradley Keller, President & CEO - Accuronix Therapeutic Inc.
  7. ADP
    CP
    • Other
    Kevin Morrissey
    Kevin Morrissey, Sales Executive - ADP
  8. ADvantage Therapeutics Inc.
    CP
    • CNS/Neurological
    Jeffrey Madden
    Jeffrey Madden, CEO - ADvantage Therapeutics Inc.
  9. AIVITA Biomedical, Inc.
    CP
    • Oncology
    Company Presentation Theater 2
    Hans Keirstead
    Hans Keirstead, Chairman & CEO - AiVita Biomedical, Inc.
  10. Alphyn Biologics, Inc.
    CP
    • Dermatology
    Neal Koller
    Neal Koller, Chairman & CEO - Alphyn Biologics
  11. Amgen Inc.
    CP
    • Multiple Therapeutics
    Company Presentation Theater 2
    Omari Wise
    Omari Wise, Vice President Business Development - Amgen
  12. Ananda Devices
    CP
    • Tools/Drug Development Support Tech
    Margaret Magdesian
    Margaret Magdesian, CEO and Founder - Ananda Devices
  13. Apollomics
    CP
    • Oncology
    Company Presentation Theater 2
    Sanjeev Redkar
    Sanjeev Redkar, President and Co-founder - Apollomics
  14. ARC Medical Inc.
    CP
    • Medical Devices
    Andrew Rae
    Andrew Rae, Consultant to ARC - Financing and Business Development - ARC Medical Inc.
  15. Artax Biopharma
    CP
    • Immunology
    Company Presentation Theater 2
    Christopher VanDeusen
    Christopher VanDeusen, Chief Scientific Officer - Artax Biopharma
  16. Aruna Bio
    CP
    • CNS/Neurological
    Stephen From
    Stephen From, CEO - Aruna Bio
  17. Asahi Kasei Pharma corporation
    CP
    • Immunology
    Company Presentation Theater 2
    Takeshi Ohno
    Takeshi Ohno, Executive Officer - Asahi Kasei Pharma Corporation
  18. Aurion Biotech
    CP
    • Cell and Gene Therapy and Genome Editing
    Greg Kunst
    Greg Kunst, CEO - Aurion Biotech
  19. AustarPharma,LLC
    CP
    • Metabolic Diseases
    Company Presentation Theater 2
    Ron Liu
    Ron Liu, CEO - AustarPharma, LLC
  20. Auxergen, Inc.
    CP
    • Food and Agriculture
    Company Presentation Theater 2
    Gregory Contreras
    Gregory Contreras, C.E.O. - Auxergen, Inc
  21. Avanzanite Bioscience
    CP
    • Orphan and Rare Disease
    Eva Cruz de Castro
    Eva Cruz de Castro, Chief Business Development Officer - Avanzanite Bioscience
  22. Avelos Therapeutics
    CP
    • Oncology
    Young-Whan Park
    Young-Whan Park, CEO - Avelos Therapeutics
  23. Avery Therapeutics, Inc.
    CP
    • Platform for Therapeutics
    Jordan Lancaster
    Jordan Lancaster, Chief Executive Officer - Avery Therapeutics, Inc.
  24. Avidicure B.V.
    CP
    • Oncology
    Robert Friesen
    Robert Friesen, Chief Scientific Officer - Avidicure B.V.
  25. Avistone Biotechnology
    CP
    • Oncology
    David Chung
    David Chung, Chief Business Officer - Avistone Biotechnology
  26. Avstera Therapeutics Corp.
    CP
    • Oncology
    Karthik Musunuri
    Karthik Musunuri, CEO & Co-Founder - Avstera Therapeutics Corp.
  27. Azitra Inc.
    CP
    • Dermatology
    Travis Whitfill
    Travis Whitfill, Chief Operating Officer - Azitra Inc.
  28. Azome Therapeutics Inc
    CP
    • Inflammation
    Elliott Gruskin
    Elliott Gruskin, CEO - Azome Therapeutics, Inc
  29. BERTIS
    CP
    • Diagnostics and Personalized Medicine
    Donghan Lee
    Donghan Lee, Strategic planning team leader - BERTIS
  30. Bexion Pharmaceuticals
    CP
    • Oncology
    Scott Shively
    Scott Shively, CEO - Bexion Pharmaceuticals
  31. Bilayer Therapeutics, Inc.
    CP
    • Metabolic Diseases
    Company Presentation Theater 2
    Thomas Collet
    Thomas Collet, President & CEO, Co-Founder - Bilayer Therapeutics, Inc.
  32. BioMap
    CP
    • Platform for Therapeutics
    Per Greisen
    Per Greisen, President - BioMap
  33. Bionaut
    CP
    • CNS/Neurological
    Michael Shipgelmacher
    Michael Shipgelmacher, CEO & Founder - Bionaut
  34. Bionomics Ltd
    CP
    • CNS/Neurological
    Spyros Papapetropoulos
    Spyros Papapetropoulos, President and CEO - Bionomics Ltd
  35. Bionoxx Inc.
    CP
    • Oncology
    Euna Cho
    Euna Cho, Director - Bionoxx Inc.
  36. Biopico Systems Inc
    CP
    • Tools/Drug Development Support Tech
    John Collins
    John Collins, CEO - Biopico Systems Inc
  37. Biorchestra
    CP
    • CNS/Neurological
    Company Presentation Theater 2
    David Oxley
    David Oxley, Chief Business Officer - Biorchestra
  38. BlueSphere Bio
    CP
    • Cell and Gene Therapy and Genome Editing
    Keir Loiacono
    Keir Loiacono, Chief Executive Officer - BlueSphere Bio
  39. Boehringer Ingelheim
    CP
    • Multiple Therapeutics
    Company Presentation Theater 2
    Scott DeWire
    Scott DeWire, US Head, Business Development & Licensing - Boehringer Ingelheim
  40. Boehringer Ingelheim Animal Health
    CP
    • Animal Health Products
    Company Presentation Theater 2
    Megan Grether
    Megan Grether, Head of Global Business Development & Licensing, Animal Health - Boehringer Ingelheim International GmbH
  41. Boryung Co., Ltd.
    CP
    • Oncology
    Bong Seog Kim
    Bong Seog Kim, CTO - BORYUNG CO., LTD.
  42. BrainStorm Therapeutics, Inc.
    CP
    • CNS/Neurological
    Robert Fremeau
    Robert Fremeau, Founder and CSO - BrainStorm Therapeutics, Inc.
  43. Breye Therapeutics
    CP
    • Ophthalmology
    Ulrik Mouritzen
    Ulrik Mouritzen, CEO - Breye Therapeutics
  44. Bridge Biotherapeutics
    CP
    • Multiple Therapeutics
    Pavel Printsev
    Pavel Printsev, Director, Business Development - Bridge Biotherapeutics
  45. Brii Biosciences
    CP
    • Multiple Therapeutics
    Company Presentation Theater 2
    Susannah Cantrell
    Susannah Cantrell, Chief Business Officer - Brii Biosciences
  46. Bristol Myers Squibb
    CP
    • Multiple Therapeutics
    Company Presentation Theater 2
    Lauren Cautilli
    Lauren Cautilli, Manager, SBD External Event Operations - Bristol Myers Squibb
  47. BTB Therapeutics
    CP
    • Pain Management
    Takashi Kiyoizumi
    Takashi Kiyoizumi, CFO - BTB Therapeutics
  48. Cairn Therapeutics
    CP
    • Oncology
    Scott Evangelista
    Scott Evangelista, Chief Executive Officer - Cairn Therapeutics
  49. Caliway Biopharmaceuticals Co.,Ltd.
    CP
    • Multiple Therapeutics
    Company Presentation Theater 2
    April Yuan
    April Yuan, VP, Business Development & Public Affairs - Caliway
  50. Calviri
    CP
    • Oncology
    Company Presentation Theater 2
  51. CeleCor Therapeutics
    CP
    • Cardiovascular
    Robert Hillman
    Robert Hillman, CEO - CeleCor Therapeutics
  52. Cellphire Therapeutics, Inc
    CP
    • Multiple Therapeutics
    Mike Gaffney
    Mike Gaffney, CEO - Cellphire Therapeutics, Inc
  53. Cellusion Inc.
    CP
    • Cell and Gene Therapy and Genome Editing
    Shin Hatou
    Shin Hatou, Cheaf Excecutive Officer - Cellusion Inc.
  54. Centivax, Inc.
    CP
    • Infectious Disease and Vaccines
    Company Presentation Theater 2
    Jacob Glanville
    Jacob Glanville, Founder & CEO - Centivax
  55. Ceria Therapeutics, Inc.
    CP
    • Platform for Therapeutics
    David Jackson
    David Jackson, CEO - Ceria Therapeutics, Inc.
  56. Chimeric Therapeutics
    CP
    • Cell and Gene Therapy and Genome Editing
    Rebecca McQualter
    Rebecca McQualter, COO - Chimeric
  57. Chugai Pharmaceutical Co., Ltd.
    CP
    • Multiple Therapeutics
    Company Presentation Theater 2
    Yumiko Asano
    Yumiko Asano, Head of Chugai Partnering - Chugai Pharmaceutical Co., Ltd.
  58. Coastar Therapeutics Inc.
    CP
    • Cell and Gene Therapy and Genome Editing
    Eddie Chung
    Eddie Chung, CEO - Coastar Therapeutics Inc.
  59. Combined Therapeutics
    CP
    • Immunology
    Romain Micol
    Romain Micol, President and co-founder CEO - Combined Therapeutics
  60. Concerto Biosciences
    CP
    • Platform for Therapeutics
    Cheri Ackerman
    Cheri Ackerman, CEO & Cofounder - Concerto Biosciences
  61. CorrectSequence Therapeutics
    CP
    • Cell and Gene Therapy and Genome Editing
    Xiaodun (Susan) Mou
    Xiaodun (Susan) Mou, CEO - CorrectSequence Therapeutics
  62. Cradle
    CP
    • Tools/Drug Development Support Tech
    Elise de Reus
    Elise de Reus, Co-Founder - Cradle
  63. Cytimm Therapeutics
    CP
    • Oncology
    Haining Huang
    Haining Huang, President - Cytimm Therapeutics
  64. Cytiva
    CP
    • Multiple Therapeutics
    Company Presentation Theater 2
    Katrin Herrmann
    Katrin Herrmann, Senior Director, Global Strategic Accounts - Cytiva
  65. Cytotheryx
    CP
    • Platform for Therapeutics
    John Swart
    John Swart, CEO - Cytotheryx
  66. Daré Bioscience
    CP
    • Reproductive/Sexual Health
  67. Data4Cure, Inc.
    CP
    • Tools/Drug Development Support Tech
    Janusz Dutkowski
    Janusz Dutkowski, CEO and Co-founder - Data4Cure, Inc.
  68. Deep Genomics
    CP
    • Platform for Therapeutics
    Brendan Frey
    Brendan Frey, Founder, Chief Innovation Officer - Deep Genomics
  69. DermaXon LLC
    CP
    • Dermatology
    Philippe Diaz
    Philippe Diaz, CEO - Dermaxon Llc
  70. Diakonos Oncology
    CP
    • Oncology
    Company Presentation Theater 2
    Anthony Baldor
    Anthony Baldor, CFO and Head of Business Development - Diakonos Oncology
  71. Doloromics
    CP
    • Pain Management
    Jackson Brougher
    Jackson Brougher, Chief Science Officer - Doloromics
  72. Dyadic International Inc.
    CP
    • Platform for Therapeutics
    Mark Emalfarb
    Mark Emalfarb, Chief Executive Officer - Dyadic International, Inc.
  73. Editpep
    CP
    • CNS/Neurological
    Company Presentation Theater 2
    Genine Winslow
    Genine Winslow, CEO - Editpep
  74. EG 427
    CP
    • Cell and Gene Therapy and Genome Editing
    Don Haut
    Don Haut, Chief Business Officer - EG 427
  75. Elanco Animal Health
    CP
    • Animal Health Products
    Company Presentation Theater 2
    Steve Nanchen
    Steve Nanchen, Snr Director - Elanco Animal Health
  76. ELEM Biotech
    CP
    • Tools/Drug Development Support Tech
    Mariano Vázquez
    Mariano Vázquez, CEO - ELEM Biotech
  77. Eli Lilly and Company
    CP
    • Multiple Therapeutics
    Company Presentation Theater 2
    Julie Gilmore
    Julie Gilmore, Vice President - Global Head of Gateway Labs - Eli Lilly and Company
  78. Enveda Biosciences
    CP
    • Inflammation
    Bigyan Bista
    Bigyan Bista, Senior Vice President, Head of Business Strategy and Development - Enveda Biosciences
  79. EpiAxis Therapeutics
    CP
    • Oncology
    Jeremy Chrisp
    Jeremy Chrisp, CEO - EpiAxis Therapeutics
  80. Epion Therapeutics
    CP
    • Ophthalmology
    Michael Webb
    Michael Webb, President & CEO - Epion Therapeutics, Inc.
  81. Esphera SynBio Inc
    CP
    • Oncology
    Brian Lichty
    Brian Lichty, CEO - Esphera SynBio Inc
  82. Evaxion Biotech
    CP
    • Immunology
    Company Presentation Theater 2
    Christian Kanstrup
    Christian Kanstrup, CEO - Evaxion Biotech
  83. Exeliom Biosciences
    CP
    • Inflammation
    Benjamin Hadida
    Benjamin Hadida, CEO - Exeliom Biosciences
  84. Extend Biosciences
    CP
    • Metabolic Diseases
    Company Presentation Theater 2
    Tarik Soliman
    Tarik Soliman, CEO and President - Extend Biosciences
  85. Eydisbio Inc.
    CP
    • Orphan and Rare Disease
    Scott Scarneo
    Scott Scarneo, Selective small molecule targeting of TAK1/TNF signaling in systemic sclerosis - EydisBio Inc.
  86. FibroBiologics Clinical Update
    CP
    • Regenerative Medicine
    Pete OHeeron
    Pete OHeeron, Founder/CEO - FibroBiologics
  87. First Wave BioPharma, Inc.
    CP
    • Gastrointestinal
    James Sapirstein
    James Sapirstein, Chairman and CEO - First Wave BioPharma, Inc.
  88. Forge Biologics
    CP
    • Cell and Gene Therapy and Genome Editing
    Taleen Barsoumian
    Taleen Barsoumian, Vice President - Forge Biologics
  89. Freedom Biosciences
    CP
    • CNS/Neurological
    Dina Burkitbayeva
    Dina Burkitbayeva, CEO - Freedom Biosciences
  90. Future Medicine
    CP
    • Metabolic Diseases
    Company Presentation Theater 2
    Jangyoun Hwang
    Jangyoun Hwang, Director - Future Medicine
  91. Gan & Lee Pharmaceuticals
    CP
    • Multiple Therapeutics
    Company Presentation Theater 2
    Spencer Carter
    Spencer Carter, Sr Director, US Business Development - Gan&Lee Pharmaceuticals
  92. GC Cell
    CP
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 2
    James Park
    James Park, Chief Executive Officer - GC Cell
  93. GelMEDIX, Inc.
    CP
    • Ophthalmology
    Max Cotler
    Max Cotler, COO - GelMEDIX, Inc
  94. GenEdit
    CP
    • Multiple Therapeutics
    Barbara Leyman
    Barbara Leyman, SVP, Corporate Development - GenEdit
  95. GenEndeavor LLC
    CP
    • Diagnostics and Personalized Medicine
    Ricardo Mancebo
    Ricardo Mancebo, CEO - GenEndeavor LLC
  96. Genentech, a Member of the Roche Group
    CP
    • Multiple Therapeutics
    Company Presentation Theater 2
    Ajay Narasimha
    Ajay Narasimha, Executive Director, Immunology, Infectious Disease, Cardiovascular/Metabolism, Pharma Partnering - Genentech
  97. GeneVentiv Therapeutics, Inc.
    CP
    • Cell and Gene Therapy and Genome Editing
    Damon Race
    Damon Race, CEO - GeneVentiv Therapeutics, Inc.
  98. Genprex, Inc.
    CP
    • Cell and Gene Therapy and Genome Editing
    Ryan Confer
    Ryan Confer, Chief Financial Officer - Genprex, Inc.
  99. GenVivo, Inc.
    CP
    • Oncology
    Robert Johnson
    Robert Johnson, COO - GenVivo
  100. GeoVax Labs, Inc.
    CP
    • Immunology
    Company Presentation Theater 2
    David Dodd
    David Dodd, Chairman & CEO - GeoVax Labs, Inc.
  101. GlueTacs Therapeutics
    CP
    • Oncology
    Rob Sons
    Rob Sons, Head of Business Development, North America - GlueTacs Therapeutics
  102. Glykos Finland Oy
    CP
    • Oncology
    Juhani Saarinen
    Juhani Saarinen, CEO - Glykos Finland Oy
  103. Greenwich LifeSciences
    CP
    • Oncology
    Company Presentation Theater 2
    Snehal PATEL
    Snehal PATEL, CEO - Greenwich Lifesciences, Inc.
  104. Gritgen Therapeutics Co., Ltd.
    CP
    • Cell and Gene Therapy and Genome Editing
    Company Presentation Theater 2
    Fenglan Wu
    Fenglan Wu, Co-founder and CEO - Gritgen Therapeutics
  105. GSK
    CP
    • Multiline Global Biopharma
    Company Presentation Theater 2
    Jeannie Rojas
    Jeannie Rojas, Senior Director - Business Development, Transactions - GSK
  106. GSNO Therapeutics, Inc.
    CP
    • Immunology
    Matthews Bradley
    Matthews Bradley, CEO and Founder - GSNO Therapeutics, Inc.
  107. Guangzhou Magpie Pharmaceuticals Co., Ltd.
    CP
    • CNS/Neurological
    Yuqiang Wang
    Yuqiang Wang, Chief Executive Officer - Guangzhou Magpie Pharmaceuticals CO., LTD.
  108. Hillhurst Bio
    CP
    • Multiple Therapeutics
    Company Presentation Theater 2
    Andrew Gomperts
    Andrew Gomperts, President and CEO - Hillhurst Bio
  109. Hopstem Biotechnology
    CP
    • CNS/Neurological
    Company Presentation Theater 2
    Jing Fan
    Jing Fan, Founder and CEO - Hopstem Biotechnology
  110. Hua Medicine
    CP
    • Metabolic Diseases
    Company Presentation Theater 2
    George Lin
    George Lin, EVP & Chief Strategy Officer - Hua Medicine
  111. Humanetics Corporation
    CP
    • Multiple Therapeutics
    Ronald Zenk
    Ronald Zenk, Chief Executive Officer - Humanetics Corporation
  112. HysensBio
    CP
    • Regenerative Medicine
    Yurim Shin
    Yurim Shin, Medical Director - HysensBio
  113. Immunartes LLC
    CP
    • Infectious Disease and Vaccines
    Company Presentation Theater 2
    Vilasack Thammavongsa
    Vilasack Thammavongsa, CEO & Director of Research - Immunartes LLC
  114. Immunic Therapeutics
    CP
    • CNS/Neurological
    Jessica Breu
    Jessica Breu, Vice President, Investor Relations and Communications - Immunic Therapeutics
  115. Immunis, Inc.
    CP
    • Cell and Gene Therapy and Genome Editing
    Hans Keirstead
    Hans Keirstead, Chairman of the Board - Immunis, Inc.
  116. ImmunoForge Co., Ltd.
    CP
    • Orphan and Rare Disease
    Jim Ballance
    Jim Ballance, Chief Technology Officer - ImmunoForge Co. Ltd.
  117. Immuto Scientific
    CP
    • Platform for Therapeutics
    Faraz Choudhury
    Faraz Choudhury, CEO - Immuto Scientific
  118. Indee Labs
    CP
    • Cell and Gene Therapy and Genome Editing
    Ryan Pawell
    Ryan Pawell, CEO - Indee Labs
  119. Inhalon Biopharma, Inc.
    CP
    • Respiratory
    John Whelan
    John Whelan, President, CEO - Inhalon, Biopharma, Inc.
  120. Inimmune Inc.
    CP
    • Immunology
    Alan Joslyn
    Alan Joslyn, Chief Executive Officer - Inimmune Inc.
  121. Inocras Inc.
    CP
    • Diagnostics and Personalized Medicine
    Jehee Suh
    Jehee Suh, CEO - Inocras Inc.
  122. inSoma Bio
    CP
    • Regenerative Medicine
    Stefan Roberts
    Stefan Roberts, CEO - InSoma Bio
  123. InVivo Biosystems
    CP
    • CNS/Neurological
    Kat McCormick
    Kat McCormick, CEO - InVivo Biosystems
  124. InvivoSciences, Inc.
    CP
    • Cardiovascular
    Ayla Annac
    Ayla Annac, CEO/Co-Founder - InvivoSciences, Inc.
  125. IRBM
    CP
    • Multiple Therapeutics
    Company Presentation Theater 2
    Carlo Toniatti
    Carlo Toniatti, Chief Scientific Officer - IRBM
  126. Juncell Therapeutics
    CP
    • Cell and Gene Therapy and Genome Editing
    Ross Ma
    Ross Ma, Head of Business Development - Juncell Therapeutics
  127. KAHR Bio
    CP
    • Oncology
    Yaron Pereg
    Yaron Pereg, CEO - Kahr Medical Ltd.
  128. Kannalife Sciences, Inc.
    CP
    • Inflammation
    Dean Petkanas
    Dean Petkanas, Chief Executive Officer - Kannalife Sciences, Inc.
  129. Kayothera
    CP
    • Platform for Therapeutics
    Mark Esposito
    Mark Esposito, Founder & VP - Kayothera Inc
  130. Kinoxis Therapeutics
    CP
    • CNS/Neurological
    Hugh Alsop
    Hugh Alsop, CEO - Kinoxis Therapeutics Pty Ltd
  131. Know Labs, Inc.
    CP
    • Medical Devices
    Leo Trautwein
    Leo Trautwein, Chief Commercial Officer - Know Labs
  132. L&J Bio,Co.,Ltd.
    CP
    • CNS/Neurological
    Company Presentation Theater 2
  133. Lectenz Bio
    CP
    • Tools/Drug Development Support Tech
    Lori Yang
    Lori Yang, CEO and CSO - Lectenz Bio
  134. Likarda, Inc
    CP
    • Platform for Therapeutics
    Stella Vnook
    Stella Vnook, CEO - Likarda
  135. Lineage Cell Therapeutics
    CP
    • Regenerative Medicine
    Brian Culley
    Brian Culley, CEO - Lineage Cell Therapeutics
  136. Lisata Therapeutics
    CP
    • Oncology
    David Mazzo
    David Mazzo, President and Chief Executive Officer - Lisata Therapeutics
  137. Lumos Pharma
    CP
    • Orphan and Rare Disease
    Aaron Schuchart
    Aaron Schuchart, Chief Business Officer - Lumos Pharma
  138. Lynk Pharmaceuticals
    CP
    • Multiple Therapeutics
    Michael Vazquez
    Michael Vazquez, Co-Founder & Executive VP (Head of Chemistry) - Lynk Pharmaceuticals
  139. Lynthera Corporation
    CP
    • Ophthalmology
    Jeff Yang
    Jeff Yang, President & CEO - Lynthera Corporation
  140. Macrobiome Therapeutics
    CP
    • Immunology
    Alex Loukas
    Alex Loukas, Founding Director - Macrobiome Therapeutics
  141. MAIA Biotechnology, Inc.
    CP
    • Oncology
    Vlad Vitoc
    Vlad Vitoc, Founder, Chairman and CEO - MAIA Biotechnology
  142. Medicus Pharma LTD.
    CP
    • Dermatology
    Erica Monaco
    Erica Monaco, Chief Operating Officer - Medicus Pharma
  143. Mediwhale Inc.
    CP
    • AI and Digital Health
    Kevin Choi
    Kevin Choi, CEO - Mediwhale
  144. Medosome Biotec, LLC
    CP
    • Multiple Therapeutics
    Richard Wagner
    Richard Wagner, President - Medosome Biotec, LLC
  145. Mekonos
    CP
    • Cell and Gene Therapy and Genome Editing
    Anil Narasimha
    Anil Narasimha, Co-Founder & Chief Executive Officer - Mekonos
  146. Merck
    CP
    • Multiple Therapeutics
    Company Presentation Theater 2
    Grace Han McMahon
    Grace Han McMahon, Associate Vice President and Head of Merck’s BD&L Pacific Innovation Hub - Merck
  147. Miracure Biotechnology
    CP
    • Infectious Disease and Vaccines
    Company Presentation Theater 2
    Xiaolin Li
    Xiaolin Li, FOUNDER/CEO - Miracure Biotechnology
  148. miRecule Inc.
    CP
    • Platform for Therapeutics
    Anthony Saleh
    Anthony Saleh, CEO/Founder - miRecule Inc.
  149. Modality.AI, Inc.
    CP
    • CNS/Neurological
    David Suendermann-Oeft
    David Suendermann-Oeft, CEO - Modality.AI
  150. Moonwalk Biosciences, Inc.
    CP
    • Cell and Gene Therapy and Genome Editing
    Alex Aravanis
    Alex Aravanis, CEO - Moonwalk Biosciences
  151. Neuracle Genetics
    CP
    • Ophthalmology
    Sunwoo Kim
    Sunwoo Kim, Head of Business Development - Neuracle Genetics
  152. Neuren Pharmaceuticals
    CP
    • CNS/Neurological
    Jon Pilcher
    Jon Pilcher, CEO - Neuren Pharmaceuticals
  153. Neurobiogen
    CP
    • CNS/Neurological
    Company Presentation Theater 2
    Changjoon Lee
    Changjoon Lee, professor and scientific advisory board - Neurobiogen
  154. Novartis
    CP
    • Other
    Company Presentation Theater 2
    Adam Feire
    Adam Feire, Global Head of Search & Evaluation - Novartis
  155. Novartis
    CP
    • Other
    Company Presentation Theater 2
    Adam Feire
    Adam Feire, Global Head of Search & Evaluation - Novartis
  156. Novo Nordisk
    CP
    • Metabolic Diseases
    Company Presentation Theater 2
    Tari Suprapto
    Tari Suprapto, Director, Search & Evaluation (Western US & Canada) - Novo Nordisk
  157. Novoron Bioscience
    CP
    • CNS/Neurological
    Company Presentation Theater 2
    Travis Stiles
    Travis Stiles, CEO & CSO - Novoron Bioscience, Inc.
  158. Nxera Pharma
    CP
    • Multiple Therapeutics
    Company Presentation Theater 2
    Chris Cargill
    Chris Cargill, Chief Executive Officer - Nxera Pharma
  159. OBI Pharma, Inc.
    CP
    • Oncology
    Company Presentation Theater 2
    Teng-Yi Huang
    Teng-Yi Huang, Director, R&D Medicinal Chemistry - OBI Pharma, Inc.
  160. Ocugen, Inc.
    CP
    • Cell and Gene Therapy and Genome Editing
    Shankar Musunuri
    Shankar Musunuri, Chairman, CEO and Co-Founder - Ocugen, Inc.
  161. Olatec Therapeutics
    CP
    • Inflammation
    Mustafa Noor
    Mustafa Noor, Chief Medical Officer - Olatec Theapeutics
  162. Orca Bio
    CP
    • Oncology
    Company Presentation Theater 2
    Dan Kirby
    Dan Kirby, Chief Commercial Officer - Orca Bio
  163. Orizuru Therapeutics, Inc.
    CP
    • Cell and Gene Therapy and Genome Editing
    Shinji Ogawa
    Shinji Ogawa, Vice president and Chief Operating Officer - Orizuru Therapeutics, Inc.
  164. Osmol Therapeutics, Inc.
    CP
    • Oncology
    Bob Linke
    Bob Linke, President & CEO - Osmol Therapeutics, Inc.
  165. Oxford Biotherapeutics
    CP
    • Oncology
    Mattthew Metzger
    Mattthew Metzger, Program, Alliance and Business Development Manager - Oxford Biotherapeutics
  166. Panolos Bioscience, Inc.
    CP
    • Multiple Therapeutics
    Company Presentation Theater 2
    David Yang
    David Yang, Research Director - Panolos Bioscience, Inc.
  167. Papillon Therapeutics, Inc.
    CP
    • Cell and Gene Therapy and Genome Editing
    Carter Cliff
    Carter Cliff, CEO - Papillon Therapeutics, Inc.
  168. PassPort Technologies, Inc.
    CP
    • Platform for Therapeutics
    Jeremiah Meloch
    Jeremiah Meloch, Business Development Representative - PassPort Technologies Inc.
  169. Pattern Computer
    CP
    • Tools/Drug Development Support Tech
    Mark Anderson
    Mark Anderson, Chair and CEO - Pattern Computer
  170. PDX Pharmaceuticals
    CP
    • Oncology
    Worapol Ngamcherdtrakul
    Worapol Ngamcherdtrakul, COO - PDX Pharmaceuticals
  171. Pelagos Pharmaceuticals, Inc.
    CP
    • Cardiovascular
    Dan Watkins
    Dan Watkins, CEO - Pelagos Pharmaceuticals, Inc.
  172. Pending AI
    CP
    • Platform for Therapeutics
    David Cardoso
    David Cardoso, Vice President, Business Development and Strategy - Pending AI
  173. Pepper Bio
    CP
    • Oncology
    Samantha Dale Strasser
    Samantha Dale Strasser, CSO and Cofounder - Pepper Bio
  174. Percheron Therapeutics Limited
    CP
    • Orphan and Rare Disease
    James Garner
    James Garner, Chief Executive Officer - Percheron Therapeutics Limited
  175. Phrontline Biopharma
    CP
    • Oncology
    Tony (Zhaoyuan) Chen
    Tony (Zhaoyuan) Chen, CEO - Phrontline Biopharma
  176. Pirouette Medical Inc.
    CP
    • Medical Devices
    Conor Cullinane
    Conor Cullinane, President, CEO - Pirouette Medical Inc.
  177. PlantPharm Biomed, Ltd
    CP
    • Infectious Disease and Vaccines
    Company Presentation Theater 2
    Richard Matner
    Richard Matner, President and Chief Strategy Officer - PlantPharm Biomed, Ltd
  178. PlaqueTec
    CP
    • Cardiovascular
    Simon Williams
    Simon Williams, General Manager - PlaqueTec
  179. Praetego Inc
    CP
    • CNS/Neurological
    Company Presentation Theater 2
    Pepper Landson
    Pepper Landson, CEO - Praetego Inc
  180. Predictive Oncology
    CP
    • Oncology
    Raymond Vennare
    Raymond Vennare, Chief Executive Officer - Predictive Oncology
  181. Profluent Bio
    CP
    • Cell and Gene Therapy and Genome Editing
    Hilary Eaton
    Hilary Eaton, Chief Business Officer - Profluent Bio
  182. ProtaBody, Inc.
    CP
    • Multiple Therapeutics
    Company Presentation Theater 2
    Justin Chartron
    Justin Chartron, CSO - ProtaBody, Inc.
  183. Protalix Biotherapeutics
    CP
    • Cell and Gene Therapy and Genome Editing
    Dror Bashan
    Dror Bashan, President & CEO - Protalix Biotherapeutics
  184. Psilera
    CP
    • CNS/Neurological
    Company Presentation Theater 2
    Chris Witowski
    Chris Witowski, Co-Founder and CEO - Psilera
  185. QBiotics Group Limited
    CP
    • Oncology
    Victoria Gordon
    Victoria Gordon, Executive Director Strategic Alliances & Investor Relations - QBiotics Group Limited
  186. Qprotyn Inc
    CP
    • Platform for Therapeutics
    Janak Vadgama
    Janak Vadgama, Head of BD and Customer Experience - Qprotyn Inc
  187. RADIOPHARM THERANOSTICS
    CP
    • Oncology
    Riccardo Canevari
    Riccardo Canevari, CEO - Radiopharm Theranostics
  188. Rakuten Medical, Inc.
    CP
    • Oncology
    Abhijit Bhatia
    Abhijit Bhatia, Chief Operating Officer - Rakuten Medical, Inc.
  189. Recce Pharmaceuticals
    CP
    • Infectious Disease and Vaccines
    Company Presentation Theater 2
    James Graham
    James Graham, CEO - Recce Pharmaceuticals
  190. ReCode Therapeutics
    CP
    • Other
    Ariel Kantor
    Ariel Kantor, Head of Business and Corporate Development - ReCode Therapeutics
  191. Rejuvenate Biomed
    CP
    • Platform for Therapeutics
    Ann Belien
    Ann Belien, Founder & CEO - Rejuvenate Biomed
  192. Rejuvenation Technologies
    CP
    • Regenerative Medicine
    John Ramunas
    John Ramunas, CEO & Founder - Rejuvenation Technologies
  193. Resilience
    CP
    • Contract Manufacturing Organization
    Milan Tomic
    Milan Tomic, Senior Director, Process Development - Resilience
  194. Reveal Pharma
    CP
    • Oncology
    Srini Mukundan
    Srini Mukundan, Medical Director - Reveal Pharmaceuticals Inc
  195. Sanofi
    CP
    • Multiple Therapeutics
    Company Presentation Theater 2
    Ulrich Wendt
    Ulrich Wendt, Global Head of Business Development, Immunology & Inflammation - Sanofi
  196. Sarcomatrix Therapeutics Corp.
    CP
    • Cell and Gene Therapy and Genome Editing
    David Craig
    David Craig, President and CEO - Sarcomatrix Therapeutics Corp
  197. scPharmaceuticals
    CP
    • Cardiovascular
    John Mohr
    John Mohr, SVP, Clinical Development and Medical Affairs - scPharmaceuticals
  198. Sernova Corp
    CP
    • Cell and Gene Therapy and Genome Editing
    Cynthia Pussinen
    Cynthia Pussinen, CEO - Sernova
  199. Serpass Biologics, Inc.
    CP
    • Inflammation
    Alexandra Lucas
    Alexandra Lucas, Professor - Serpass Biologics inc.
  200. Servier
    CP
    • Oncology
    Company Presentation Theater 2
    Frédéric Scaerou
    Frédéric Scaerou, Head of Global Business Development - Servier
  201. Shanghai Novamab Biopharmaceuticals Co., Ltd.
    CP
    • Immunology
    Company Presentation Theater 2
    Yakun Wan
    Yakun Wan, CEO - Shanghai Novamab Biopharmaceuticals Co., Ltd.
  202. Shanghai Synergy Pharmaceutical Sciences Co., Ltd., A wholly owned subsidiary of Huahai Pharmaceutical Co., Ltd.
    CP
    • Multiple Therapeutics
    Min Li
    Min Li, Board Chair - Shanghai Synergy Pharmaceutical Sciences Co., Ltd.
  203. Silver Creek Pharmaceuticals
    CP
    • CNS/Neurological
    Kris Kuchenbecker
    Kris Kuchenbecker, Chief Science & Technology Officer - Silver Creek Pharmaceuticals
  204. Sinopia Biosciences, Inc.
    CP
    • CNS/Neurological
    Company Presentation Theater 2
    Iman Famili
    Iman Famili, President & CEO - Sinopia Biosciences, Inc.
  205. SIRPant Immunotherapeutics Inc
    CP
    • Cell and Gene Therapy and Genome Editing
    Robert Towarnicki
    Robert Towarnicki, President & CEO - SIRPant Immunotherapeutics Inc.
  206. Sobrera Pharma
    CP
    • CNS/Neurological
    Ann-Charlotte ROSENDAHL
    Ann-Charlotte ROSENDAHL, CEO - Sobrera Pharma
  207. SPOC Proteomics
    CP
    • Tools/Drug Development Support Tech
    Bharath Takulapalli
    Bharath Takulapalli, CEO - SPOC Proteomics, Inc.
  208. STALICLA SA
    CP
    • CNS/Neurological
    Lynn Durham
    Lynn Durham, CEO & Founder - STALICLA SA
  209. StemSynergy Therapeutics
    CP
    • Oncology
    Dennis Fei
    Dennis Fei, Director of Drug Discovery and Development - StemSynergy Therapeutics
  210. Talus Bio
    CP
    • Platform for Therapeutics
    Alex Federation
    Alex Federation, Co-Founder and CEO - Talus Bio
  211. TechInvention Lifecare Pvt Ltd
    CP
    • Infectious Disease and Vaccines
    Company Presentation Theater 2
    Syed Ahmed
    Syed Ahmed, Director & CEO - Techinvention Lifecare Private Limited
  212. Tharimmune, Inc.
    CP
    • Multiple Therapeutics
    Sireesh Appajosyula
    Sireesh Appajosyula, Chief Operating Officer - Tharimmune, Inc.
  213. Theradaptive, Inc.
    CP
    • Regenerative Medicine
    Luis Alvarez
    Luis Alvarez, President & CEO - Theradaptive, Inc.
  214. ThromBio Holdings
    CP
    • Cardiovascular
    Peter Bush
    Peter Bush, Chief Executive Officer - ThromBio
  215. Tiba Biotech LLC
    CP
    • Immunology
    Jasdave Chahal
    Jasdave Chahal, Founder and Chief Scientist - Tiba Biotech LLC
  216. Tonix Pharmaceuticals Holding Corp.
    CP
    • CNS/Neurological
    Jessica Morris
    Jessica Morris, Chief Operating Officer - TONIX Pharmaceuticals
  217. Transcend Therapeutics
    CP
    • CNS/Neurological
    Blake Mandell
    Blake Mandell, CEO - Transcend Therapeutics
  218. TransCode Therapeutics
    CP
    • Oncology
    Zdravka Medarova
    Zdravka Medarova, Chief Scientific Officer - TransCode Therapeutics
  219. Triastek, Inc.
    CP
    • Other
    Yulian Zhang
    Yulian Zhang, VP of Global BD - Triastek, Inc.
  220. Umoja Biopharma
    CP
    • Cell and Gene Therapy and Genome Editing
    David Fontana
    David Fontana, Chief Operating and Chief Business Officer - Umoja Biopharma
  221. Varda Space Industries, Inc.
    CP
    • Platform for Therapeutics
    Mark Herbert
    Mark Herbert, Vice President, Business Development - Varda Space Industries, Inc.
  222. Vasomune Therapeutics Inc
    CP
    • Respiratory
    BRIAN JAHNS
    BRIAN JAHNS, President & Chief Operating Officer - Vasomune Therapeutics inc
  223. Vaxxas
    CP
    • Medical Devices
    David Hoey
    David Hoey, Chief Executive Officer - Vaxxas
  224. VelaVigo
    CP
    • Oncology
    Tong Zhang
    Tong Zhang, Co Founder, CBO/CFO - VelaVigo
  225. Ventrix
    CP
    • Regenerative Medicine
    Adam Kinsey
    Adam Kinsey, CEO - Ventrix
  226. Virpax Pharmaceuticals, Inc.
    CP
    • Pain Management
    Gerald Bruce
    Gerald Bruce, Chief Executive Officer - Virpax Pharmaceuticals Inc.
  227. Vivacelle Bio,Inc.
    CP
    • Multiple Therapeutics
    Cuthbert Simpkins
    Cuthbert Simpkins, President/Chief Innovation Officer - Vivacelle Bio, Inc
  228. VRG Therapeutics
    CP
    • Immunology
    Zalan Peterfi
    Zalan Peterfi, MD, PhD - VRG Therapeutics
  229. VSPharmTech
    CP
    • Oncology
    HO YUN NAM
    HO YUN NAM, General Manager - VSPharmTech
  230. XORTX Therapeutics Inc.
    CP
    • Other
    Allen Davidoff
    Allen Davidoff, CEO, President, Director - XORTX Therapeutics Inc.
  231. XyloCor Therapeutics
    CP
    • Cardiovascular
  232. Yifan Pharmaceutical
    CP
    • Multiple Therapeutics
    Company Presentation Theater 2
    Simon Li
    Simon Li, CEO/CMO - Yifan Pharmaceutical
  233. YourChoice Therapeutics
    CP
    • Reproductive/Sexual Health
    Akash Bakshi
    Akash Bakshi, CEO - YourChoice Therapeutics
  234. Zambon Biotech SA
    CP
    • CNS/Neurological
    Cibele Sabido David
    Cibele Sabido David, Head of Business Development - Zambon Biotech
  235. Ziphius
    CP
    • Immunology
    Hanne Noyen
    Hanne Noyen, Scientific Liaison Manager - Ziphius
  236. Zoetis
    CP
    • Animal Health Products
    Company Presentation Theater 2
    Stephane Shu Kin So
    Stephane Shu Kin So, Director, External Innovation - Zoetis
  237. ZTI BIOSCIENCES
    CP
    • Other
    Jaden Hyungseok Chang
    Jaden Hyungseok Chang, CEO - ZTI Biosciences
  238. Zymeworks
    CP
    • Other
    Emily Chen
    Emily Chen, Associate Director, Business Development - Zymeworks

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS

Loading

Search